Check our
Open Access Repository.
2019
47 publication(s):Note: when necessary, only the first 10 authors are displayed.Articles
- 21 -
-
Intratumoral immune and stromal heterogeneity in follicular lymphoma: an implication in relapses and responses to immunotherapies?
- C. Lamaison, F. Mourcin, K. Tarte
- Virchows Archiv, 2019, 475, pp.S345-S346.
-
-
- 22 -
-
Impact of B cell/lymphoid stromal cell crosstalk in B-cell physiology and malignancy
- C. Lamaison, K. Tarte
- Immunology Letters, 2019, 215, pp.12-18.
- DOI : https://doi.org/10.1016/j.imlet.2019.02.005
- Pubmed : 30844420
-
-
- 23 -
-
Large granular lymphocytic and other rare lymphoid leukemias
- Thierry Lamy, Thomas P Loughran
- Best Practice and Research: Clinical Haematology, 2019, 32 (3), pp.193-195.
- DOI : https://doi.org/10.1016/j.beha.2019.09.001
- Pubmed : 31585619
-
-
- 24 -
-
Low Frequency of Circulating T Follicular Helper 1 Cells Is Associated to Adequate Response to Adalimumab Therapy in Rheumatoid Arthritis
- Charlotte Lucas, Roussine Codo, Jean-David Albert, Rachel Jean, Stéphane Rodriguez, Patricia Ame-Thomas, Aleth Perdriger
- Arthritis & rheumatology, 2019, 71.
-
-
- 25 -
-
Reference Values for WBC Differential by Hematoflow Analysis
- Marion Magierowicz, Nicolas Lechevalier, Nicolas Freynet, Cedric Pastoret, Bouchra Badaoui, Beatrice Ly-Sunnaram, Thierry Fest, Francis Lacombe, Orianne Wagner-Ballon, Mikaël Roussel et al.
- American journal of clinical pathology, 2019, 151 (3), pp.324-327.
- DOI : https://doi.org/10.1093/ajcp/aqy147
- Pubmed : 30383211
-
-
- 26 -
-
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
- Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, Jean-Marc Schiano, Olivier Casasnovas, Aspasia Stamatoullas, Bénédicte Deau, Anna Schmitt, Georges Garnier, Caroline Régny et al.
- European Journal of Cancer, 2019, 115, pp.47-56.
- DOI : https://doi.org/10.1016/j.ejca.2019.04.006
- Pubmed : 31082693
-
-
- 27 -
-
Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers
- L. Michel, C. Grasmuck, M. Charabati, M.-A. Lécuyer, S. Zandee, T. Dhaeze, J.I. Alvarez, R. Li, S. Larouche, L. Bourbonnière et al.
- Science Translational Medicine, 2019, 11 (518), pp.eaaw0475.
- DOI : https://doi.org/10.1126/scitranslmed.aaw0475
- Pubmed : 31723036
-
-
- 28 -
-
Actualités thérapeutiques dans la sclérose en plaques
Actualités thérapeutiques dans la sclérose en plaques [Therapeutic news in multiple sclerosis]
- L. Michel
- Actualités thérapeutiques dans la sclérose en plaques. Pratique Neurologique - FMC, 2019, 10 (3), pp.183-186.
- DOI : https://doi.org/10.1016/j.praneu.2019.07.014
-
-
- 29 -
-
Exploring T cell - B cell collaboration in multiple sclerosis through B cell differentiation analysis
- J. Morille, S. Rodriguez, P. Ame Thomas, K. Tarte, A. Garcia, L. Berthelot, A. Nicot, S. Brouard, D. A. Laplaud, L. Michel et al.
- Multiple Sclerosis Journal, 2019, 25, pp.662-663.
-
-
- 30 -
-
ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks
- A. Mouche, J. Archambeau, C. Ricordel, L. Chaillot, N. Bigot, T. Guillaudeux, M. Grenon, R. Pedeux
- Cell Death and Differentiation, 2019, 26 (11), pp.2344-2357.
- DOI : https://doi.org/10.1038/s41418-019-0305-x
- Pubmed : 30804473
-
-